Oramed Pharmaceuticals Inc. ORMP

Full chart Compare
Set alert

Price alert · ORMP

All alert types
4.00 USD 0.00 (+0.00%)

At closeNov 3, 2026, 4:33 PM EST

4.00 0.00 0.00%

After hours · Nov 3, 4:33 PM ET

3.92 Day range 4.05
2.09 52-week range 5.47
YTD
+40.35%
1 year
+69.49%

Analyst view

Price target (mean) 3.25
Ratings (0m) 1 0 buy · 1 hold · 0 sell
  • Strong buy0
  • Buy0
  • Hold1
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 1
  • 1 month ago 1

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

ORMP analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.07-0.07 – -0.070.33-121.2%00.0%1
Next quarter-0.05-0.05 – -0.050.000.0%500.00K0.0%1
Current year0.170.17 – 0.170.14+21.4%0-100.0%1
Next year-0.26-0.26 – -0.260.17-252.9%1.00M0.0%1

Upgrades and downgrades

The latest rating changes

ORMP analyst upgrades and downgrades
DateFirmActionFromTo
Sep 9, 2024HC Wainwright & Co.Reiterated—Neutral
May 20, 2024HC Wainwright & Co.Reiterated—Neutral
May 17, 2023Canaccord GenuityMaintainedHoldHold
Jan 17, 2023HC Wainwright & Co.DowngradeBuyNeutral
Jan 12, 2023Canaccord GenuityDowngradeBuyHold
May 16, 2022Aegis CapitalMaintained—Buy
Feb 18, 2022Cantor FitzgeraldInitiated—Overweight
Nov 30, 2021HC Wainwright & Co.Maintained—Buy
Nov 29, 2021HC Wainwright & Co.Maintained—Buy
Nov 2, 2021Aegis CapitalMaintained—Buy
Jul 29, 2021Canaccord GenuityMaintained—Buy
Jun 8, 2021Aegis CapitalMaintained—Buy
Apr 20, 2021Canaccord GenuityInitiated—Buy
Feb 9, 2021National Securities CorporationInitiated—Buy
Jan 27, 2021Aegis CapitalMaintained—Buy
Jul 13, 2020HC Wainwright & Co.Reiterated—Buy
Jun 22, 2020HC Wainwright & Co.Maintained—Buy
Sep 11, 2019Ladenburg ThalmannInitiated—Buy
Nov 19, 2015FBR CapitalInitiated—Outperform
Oct 1, 2015HC Wainwright & Co.Initiated—Buy
Dec 4, 2013Aegis CapitalInitiated—Buy